Log in

Relevant bibliographies by topics / Lipodystrophy syndrome

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Lipodystrophy syndrome'

Author: Grafiati

Published: 4 June 2021

Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lipodystrophy syndrome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lipodystrophy syndrome"

1

Mosbah, Héléna, Camille Vatier, Franck Boccara, et al. "Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice." Cells 9, no. 3 (2020): 765. http://dx.doi.org/10.3390/cells9030765.

Full text

Abstract:

Variants in LMNA, encoding A-type lamins, are responsible for laminopathies including muscular dystrophies, lipodystrophies, and progeroid syndromes. Cardiovascular laminopathic involvement is classically described as cardiomyopathy in striated muscle laminopathies, and arterial wall dysfunction and/or valvulopathy in lipodystrophic and/or progeroid laminopathies. We report unexpected cardiovascular phenotypes in patients with LMNA-associated lipodystrophies, illustrating the complex multitissular pathophysiology of the disease and the need for specific cardiovascular investigations in affecte

APA, Harvard, Vancouver, ISO, and other styles

2

Vijayanandh, Mani. "Lipodystrophy Syndrome." Pondicherry Journal of Nursing 13, no. 4 (2020): 89–92. http://dx.doi.org/10.5005/jp-journals-10084-12156.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Koutkia, Polyxeni, Gary Meininger, Bridget Canavan, Jeff Breu, and Steven Grinspoon. "Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy." American Journal of Physiology-Endocrinology and Metabolism 286, no. 2 (2004): E296—E303. http://dx.doi.org/10.1152/ajpendo.00335.2003.

Full text

Abstract:

Human immunodeficiency virus (HIV)-lipodystrophy is a syndrome characterized by changes in fat distribution and insulin resistance. Prior studies suggest markedly reduced growth hormone (GH) levels in association with excess visceral adiposity among patients with HIV-lipodystrophy. We investigated mechanisms of altered GH secretion in a population of 13 male HIV-infected patients with evidence of fat redistribution, compared with 10 HIV-nonlipodystrophic patients and 11 male healthy controls similar in age and body mass index (BMI). Although similar in BMI, the lipodystrophic group was charact

APA, Harvard, Vancouver, ISO, and other styles

4

Lichtenstein, Kenneth A. "Redefining Lipodystrophy Syndrome." JAIDS Journal of Acquired Immune Deficiency Syndromes 39, no. 4 (2005): 395–400. http://dx.doi.org/10.1097/01.qai.0000167478.28051.3a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Patni, Nivedita, Sarah Hatab, Chao Xing, Zhengyang Zhou, Claudia Quittner, and Abhimanyu Garg. "A novel autosomal recessive lipodystrophy syndrome due to homozygous LMNA variant." Journal of Medical Genetics 57, no. 6 (2019): 422–26. http://dx.doi.org/10.1136/jmedgenet-2019-106395.

Full text

Abstract:

BackgroundDespite major advances in understanding the molecular basis of various genetic lipodystrophy syndromes, some rare patients still remain unexplained.CasesWe report a novel autosomal recessive lipodystrophy affecting two sisters aged 17 and 19 years and characterised by early onset intellectual disability, and subsequent development of near-generalised loss of subcutaneous fat with diabetes mellitus, extreme hypertriglyceridemia, hepatic steatosis, short stature, clinodactyly, joint contractures, leiomyoma of uterus and cataracts in childhood. The lipodystrophy was more pronounced in t

APA, Harvard, Vancouver, ISO, and other styles

6

Murakhovskaya, E. V., and N. T. Starkova. "To the diagnosis of Barraquer-Simons syndrome." Problems of Endocrinology 44, no. 3 (1998): 29–31. http://dx.doi.org/10.14341/probl199844329-31.

Full text

Abstract:

Barraquer-Simons syndrome is a rare disease characterized by the disappearance of subcutaneous fat in the upper half of the body with normal or excessive deposition of fat in the lower half of the body. There are other terms that refer to this disease: Hollander-Simons syndrome, progressive lipodystrophy, partial lipodystrophy, paradoxical lipodystrophy, progressive segmental lipodystrophy, i.e. the name emphasizes the disappearance of fat in certain parts of the body.

APA, Harvard, Vancouver, ISO, and other styles

7

Qaqish, Roula B., Evelyn Fisher, John Rublein, and David A. Wohl. "HIV-Associated Lipodystrophy Syndrome." Pharmacotherapy 20, no. 1 (2000): 13–22. http://dx.doi.org/10.1592/phco.20.1.13.34667.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Abel, Brent S., Elaine K. Cochran, Megan S. Startzell, and Rebecca J. Brown. "Racial Disparities Among Clinical Trials for Inherited Forms of Lipodystrophy." Journal of the Endocrine Society 5, Supplement_1 (2021): A323—A324. http://dx.doi.org/10.1210/jendso/bvab048.660.

Full text

Abstract:

Abstract Background: There has been renewed interest in understanding how medical research serves minority communities disproportionally affected by disease. A recent study in a predominantly white population identified 12 subjects with partial lipodystrophy by genetics without clinical diagnosis of lipodystrophy (Gonzaga-Jauregui et al., 2020). Partial lipodystrophies are rare monogenic disorders leading to diabetes that can be challenging to diagnosis due to their similarity with common obesity-associated metabolic syndrome. We hypothesize minority populations may be underdiagnosed with lipo

APA, Harvard, Vancouver, ISO, and other styles

9

Capeau, J., J. Magré, O. Lascols, et al. "Diseases of adipose tissue: genetic and acquired lipodystrophies." Biochemical Society Transactions 33, no. 5 (2005): 1073–77. http://dx.doi.org/10.1042/bst0331073.

Full text

Abstract:

Human lipodystrophies represent a group of diseases characterized by altered body fat amount and/or repartition and major metabolic alterations with insulin resistance leading to diabetic complications and increased cardiovascular and hepatic risk. Genetic forms of lipodystrophies are rare. Congenital generalized lipodystrophy or Berardinelli–Seip syndrome, autosomal recessive, is characterized by a complete early lipoatrophy and severe insulin resistance and results, in most cases, from mutations either in the seipin gene of unknown function or AGPAT2 encoding an enzyme involved in triacylgly

APA, Harvard, Vancouver, ISO, and other styles

10

Behrens, Georg M. N., Matthias Stoll, and Reinhold E. Schmidt. "Lipodystrophy Syndrome in HIV Infection." Drug Safety 23, no. 1 (2000): 57–76. http://dx.doi.org/10.2165/00002018-200023010-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Lipodystrophy syndrome"

1

Van, Wyk Elmarie Charlotte. "Assessing HIV lipodystrophy syndrome : a comparison of different methods to an objective case definition." Diss., Pretoria : [s.n.], 2009. http://upetd.up.ac.za/thesis/available/etd-01252010-115537/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Berbaum, Jennifer Bentz Joe. "Investigating the role of nuclear receptors in HIV/HAART-associated dyslipidemic lipodystrophy /." Philadelphia, Pa. : Drexel University, 2007. http://hdl.handle.net/1860/1759.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Loonam, Cathriona Rosemary. "Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome." Thesis, King's College London (University of London), 2015. http://kclpure.kcl.ac.uk/portal/en/theses/prevalence-underlying-mechanisms-and-role-of-nutrition-in-the-management-of-the-hivassociated-lipodystrophy-syndrome(fbe1f1ae-e564-4b1c-ad91-bdc33b37cae8).html.

Full text

Abstract:

HIV-associated lipodystrophy syndrome (HALS) is characterised by abnormalities of body fat distribution and metabolism resulting from adipocyte dysfunction. This thesis examines the hypothesis that antiretroviral drugs (ARVs) alter PPAR-γ, which contributes to adipocyte dysfunction. We hypothesise that conjugated linoleic acid (CLA) isomers, as putative PPAR-γ ligands, will attenuate adipocyte dysfunction and HALS. In vitro, ritonavir (RTV; 20 μM) was the most potent ARV and significantly decreased triglyceride storage (P < 0.001), perilipin (P = 0.003) and Cidea expression (P < 0.001), PPAR-γ

APA, Harvard, Vancouver, ISO, and other styles

4

Alam, N. S. "Investigation of lipodystrophy syndrome in a multicentre prospective cohort of HIV-infected children and adolescents living in Europe." Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1400389/.

Full text

Abstract:

This is an investigation into lipodystrophy syndrome (LS), defined as specific body fat alterations (BFA) and/or metabolic abnormality (MA), in HIV-infected children. Antiretroviral therapy (ART) has resulted in improved disease-free survival in HIV-infected individuals, but is an established risk factor for LS. The metabolic profile seen in LS patients is similar to that seen in the early stages of cardiovascular disease. As ART coverage improves, and because treatment is life-long, the importance of LS will become more relevant, especially as treated children survive into adulthood, and accu

APA, Harvard, Vancouver, ISO, and other styles

5

Sanches, Roberta Seron. "Lipodistrofia em pacientes sob Terapia Anti-retroviral: subsídios para o cuidado de enfermagem a portadores do HIV-1." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-25032008-165647/.

Full text

Abstract:

Efeitos colaterais têm sido associados à terapia anti-retroviral em portadores da infecção pelo HIV. Entre esses, destaca-se a a síndrome da lipodistrofia, caracterizada por hiperlipidemia e lipodistrofia. A lipodistrofia é manifestada por alterações na forma do corpo, com aumento progressivo da circunferência abdominal e torácica, aparecimento de gordura dorsocervical com expansão da circunferência do pescoço; e lipoatrofia, com perda de tecido adiposo na face, nas nádegas e nos membros superiores e inferiores. O presente estudo, seccional e descritivo, realizado com 84 pacientes atendidos em

APA, Harvard, Vancouver, ISO, and other styles

6

Silva, Mariana Machado da. "Polimorfismo da região do fator de necrose tumoral (TNF) na síndrome da lipodistrofia associada à terapia anti-retroviral em portadores do HIV-1." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-27052008-144002/.

Full text

Abstract:

Apesar de causar um enorme impacto na história da evolução e prognóstico a partir da infecção pelo HIV, a terapia anti-retroviral altamente potente prolongada apresenta vários efeitos colaterais. Dentre esses, a síndrome da lipodistrofia (SL) caracterizada por alterações metabólicas e morfológicas. Embora tenha sido descrito que a adesão à terapia esteja associada, sua patogenia ainda permanece desconhecida. Um enfoque têm sido dado aos mediadores pró-inflamatórios, como o Fator de Necrose Tumoral (TNF), sugerindo que o aumento nos níveis dessa citocina esteja associado com o desenvolvimento d

APA, Harvard, Vancouver, ISO, and other styles

7

Zambrini, Heverton. "Estudo de dados e laboratoriais de pacientes com aids e lipodistrofia atendidos no Programa de Lipodistrofia do Hospital Heliópolis." Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/5/5134/tde-12012012-091947/.

Full text

Abstract:

INTRODUÇÃO: O termo lipodistrofia associada ao HIV foi introduzido aproximadamente dois anos após o início do uso dos inibidores da protease e, desde então, várias definições têm sido utilizadas para descrever a extensão das complicações morfológicas e metabólicas associadas à infecção pelo HIV e à terapia antirretroviral. Inúmeros estudos clínicos têm sido desenvolvidos nos últimos 10 anos com o objetivo de melhor definir as alterações corporais associadas à infecção pelo HIV e identificar os fatores de riscos dependentes ou independentes a essas alterações. MÉTODO: Neste estudo transversal r

APA, Harvard, Vancouver, ISO, and other styles

8

Santos, Wlaldemir Roberto dos. "Impacto do treinamento de força na síndrome da lipodistrofia em pessoas vivendo com HIV." Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-26092013-195008/.

Full text

Abstract:

A terapia antirretroviral (TARV) modificou a aids de uma doença letal para crônica. Contudo, efeitos adversos surgiram, entre eles, a síndrome da lipodistrofia, má distribuição da gordura corporal e alterações metabólicas. Potencializando o estigma da doença e pode levar ao abandono do uso da TARV, devido à \"desarmonia\" corporal causada pela infecção. Não existe tratamento para a síndrome da lipodistrofia. Porém, a literatura descreve que o treinamento de força (TF) ajuda no controle das alterações. Com isso, o presente estudo teve como objetivo avaliar o impacto do treinamento de for

APA, Harvard, Vancouver, ISO, and other styles

9

Fourie, Catharina Maria Theresia. "The influence of HIV infection on vascular function in an African population / Catharina Maria Theresia Fourie." Thesis, North-West University, 2010. http://hdl.handle.net/10394/4356.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sacilotto, Lívia Bertazzo [UNESP]. "Composição corporal e componentes da síndrome metabólica nos diferentes subtipos de lipodistrofia associada ao HIV." Universidade Estadual Paulista (UNESP), 2017. http://hdl.handle.net/11449/148978.

Full text

Abstract:

Submitted by Lívia Bertazzo Sacilotto (livia.bsacilotto@gmail.com) on 2017-03-08T06:52:01Z No. of bitstreams: 1 sacilotto_lb_me_bt.pdf: 2686215 bytes, checksum: b3f919111b6e0a1f81fe1d0c5ae28c47 (MD5)<br>Approved for entry into archive by Juliano Benedito Ferreira (julianoferreira@reitoria.unesp.br) on 2017-03-13T14:03:44Z (GMT) No. of bitstreams: 1 sacilotto_lb_me_bt.pdf: 2686215 bytes, checksum: b3f919111b6e0a1f81fe1d0c5ae28c47 (MD5)<br>Made available in DSpace on 2017-03-13T14:03:44Z (GMT). No. of bitstreams: 1 sacilotto_lb_me_bt.pdf: 2686215 bytes, checksum: b3f919111b6e0a1f81fe1d0c5ae2

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Lipodystrophy syndrome"

1

Wanke, Christine A., and Sherwood L. Gorbach, eds. Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

A, Wanke Christine, and Gorbach Sherwood L. 1934-, eds. Lipodystrophy syndrome in HIV. Kluwer Academic Publishers, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wanke, Christine A. Lipodystrophy Syndrome in Hiv. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lipodystrophhy Syndrome in HIV. Springer, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sybert, Virginia P. Disorders of Subcutaneous Tissue. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780195397666.003.0006.

Full text

Abstract:

Cerebrotendinous Xanthomatosis – Familial Multiple Lipomatosis – Familial Symmetric Lipomatosis – Fibrodysplasia Ossificans Progressiva – Lipogranulomatosis – Partial Lipodystrophy – Seip-Berardinelli Syndrome

APA, Harvard, Vancouver, ISO, and other styles

6

Sybert, Virginia P. Disorders of Subcutaneous Tissue. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190276478.003.0006.

Full text

Abstract:

Chapter 6 covers Cerebrotendinous Xanthomatosis, Familial Multiple Lipomatosis, Familial Symmetric Lipomatosis, Fibrodysplasia Ossificans Progressiva, Lipogranulomatosis, Partial Lipodystrophy, and Berardinelli-Seip Syndrome. Each condition is discussed in detail, including dermatologic features, associated anomalies, histopathology, basic defect, treatment, mode of inheritance, prenatal diagnosis, and differential diagnosis.

APA, Harvard, Vancouver, ISO, and other styles

7

Watson, Ronald R. AIDS and Heart Disease. Informa Healthcare, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

R, Watson Ronald, ed. AIDS and heart disease. M. Dekker, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lipodystrophy syndrome"

1

Shikuma, Cecilia M., Scott Souza, and Bruce Shiramizu. "Pathogenesis of HIV Lipodystrophy." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wanke, Christine, and Sherwood Gorbach. "Introduction." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wanke, Christine A. "Potential Therapies for the HIV-Associated Lipodystrophy Syndrome." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shevitz, Abby H. "Epidemiology of Fat Redistribution in HIV." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Khatami, Hootan, and Kathleen Mulligan. "Body Composition in HIV Lipodystrophy." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kotler, Donald P., and Ellen S. Engelson. "Methods for Assessing Body Composition in HIV-Associated Lipodystrophy." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Meininger, Gary, and Steven Grinspoon. "Abnormalities in Glucose and Insulin in HIV Disease." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lamon-Fava, Stefania, and Ernst J. Schaefer. "Abnormalities in Lipid Metabolism in HIV." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Miller, Tracie L. "Nutrition and Metabolism in HIV-1-Infected Children Receiving Haart Therapy." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Woods, Margo N., and Kristy M. Hendricks. "Treatment of Hyperlipidemia and Insulin Resistance with Diet." In Lipodystrophy Syndrome in HIV. Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0471-9_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lipodystrophy syndrome"

1

Nguyen, Minh HN, Nicholas B. George, Amber Fausneaucht, and Nic Helmstetter. "Challenges of Transitioning From Pediatric to Adult Care in a Patient with Lipodystrophy Syndrome." In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.619.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hansen, Laura, Manu O. Platt, Roy L. Sutliff, and Rudolph L. Gleason. "The Mechanical and Structural Changes in Murine Arteries due to the Antiretroviral Drug Azidothymidine (AZT)." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80799.

Full text

Abstract:

With over 33 million people infected with the human immunodefeciency virus (HIV-1), HIV-1 and autoimmune deficiency syndrome (AIDS) is a worldwide epidemic [1]. However, the development and widespread use of highly active antiretroviral therapy (HAART) has helped transform HIV-1 infection from a terminal disease leading to AIDS to a manageable chronic condition. With the increase in life expectancy, a new set of non-AIDS related complications has emerged including dyslipidemia, lipodystrophy, insulin resistance, diabetes mellitus, and cardiovascular disease (CVD) specifically high risks for my

APA, Harvard, Vancouver, ISO, and other styles

3

MELLO, MARCELLA MARIA SOARES, EDUARDO JOSÉ DO ROSÁRIO SOUZA, GUSTAVO LAMEGO DE BARROS COSTA, RAFAEL PRADO COLARES, ANA FLAVIA MADUREIRA DE PÁDUA DIAS, and MAYRA RABELO CAMPOS. "LIPODYSTROPHIC SYNDROME ASSOCIATED WITH DERMATOMYOSITIS." In 36º Congresso Brasileiro de Reumatologia. Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Lipodystrophy syndrome"

1

Bergero, Georgina, Ciara Keenan, and Aaron Liew. The efficacy and safety profile of leptin replacement therapy for non-HAART associated lipodystrophic syndromes: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.1.0047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!